Cash & equivalents increased 29.6%
Cash & equivalents changed +29.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +29.6% from the comparable as-filed period.
Net income changed -24.0% from the comparable as-filed period.
Operating income changed -23.2% from the comparable as-filed period.
Operating margin changed -271 basis points from the comparable as-filed period.
Stock-based compensation changed +24.2% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
Gross margin changed -183 basis points from the comparable as-filed period.
Capital expenditure changed +10.5% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
Free-cash-flow proxy changed -5.7% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Gross profit changed -5.6% from the comparable as-filed period.
Selling, general & administrative changed +6.9% from the comparable as-filed period.
Capex / revenue changed +12 basis points from the comparable as-filed period.
Inventory changed -2.4% from the comparable as-filed period.
Operating cash flow changed -3.7% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Revenue changed +1.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.